Captrust Financial Advisors Novo Nordisk A S Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Captrust Financial Advisors holds 155,212 shares of NVO stock, worth $16.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

155,212

Previous 160,823 3.49%

Holding current value

$16.8 Million

Previous $23 Million 19.49%

% of portfolio

0.06%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $668,101 - $815,951	-5,611 Reduced 3.49%	155,212 $18.5 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $1.35 Million - $1.62 Million	10,997 Added 7.34%	160,823 $23 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $505,138 - $672,396	4,947 Added 3.41%	149,826 $19.2 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $3.01 Million - $3.61 Million	34,278 Added 30.99%	144,879 $15 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $6.32 Million - $13.9 Million	69,481 Added 168.97%	110,601 $10.1 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $199,966 - $221,337	1,282 Added 3.22%	41,120 $6.65 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $578,325 - $695,441	4,370 Added 12.32%	39,838 $6.34 Million
Q4 2022 Feb 15, 2023	BUY	$102.55 - $135.33 $358,617 - $473,249	3,497 Added 10.94%	35,468 $4.8 Million
Q3 2022 Nov 16, 2022	BUY	$95.28 - $116.93 $684,777 - $840,375	7,187 Added 29.0%	31,971 $3.19 Million
Q2 2022 Aug 23, 2022	SELL	$103.24 - $121.81 $372,593 - $439,612	-3,609 Reduced 12.71%	24,784 $2.76 Million
Q2 2022 Aug 16, 2022	BUY	$103.24 - $121.81 $695,011 - $820,024	6,732 Added 31.08%	28,393 $3.16 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $272,689 - $329,629	2,929 Added 15.64%	21,661 $2.43 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $575,280 - $702,480	6,000 Added 47.13%	18,732 $2.1 Million
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $11,565 - $14,606	137 Added 1.09%	12,732 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $51,827 - $64,926	766 Added 6.48%	12,595 $1.06 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $54,586 - $61,717	814 Added 7.39%	11,829 $808,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $137,363 - $158,670	-2,150 Reduced 16.33%	11,015 $769,000
Q3 2020 Nov 17, 2020	BUY	$63.69 - $70.22 $99,547 - $109,753	1,563 Added 13.47%	13,165 $912,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $173,044 - $200,830	2,956 Added 34.19%	11,602 $762,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $6,578 - $8,615	133 Added 1.56%	8,646 $523,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $424,458 - $495,967	8,513 New	8,513 $497,000

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Novo Nordisk A S Transaction History